• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他莫昔芬可刺激耐药物雌激素受体阴性乳腺癌在体内的生长。

Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer.

作者信息

Maenpaa J, Wiebe V, Koester S, Wurz G, Emshoff V, Seymour R, Sipila P, DeGregorio M

机构信息

Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7884.

出版信息

Cancer Chemother Pharmacol. 1993;32(5):396-8. doi: 10.1007/BF00735926.

DOI:10.1007/BF00735926
PMID:8339392
Abstract

An estrogen receptor-negative, multidrug-resistant MDA-MB-A1 human breast cancer cell line was grown in culture with and without a noninhibitory concentration (0.5 microM) of tamoxifen for 122 days. Tamoxifen-treated and control cells were inoculated into opposite flanks of nine nude mice, where they produced measurable tumors in every case. Six of the animals were treated with tamoxifen at 500 micrograms/day for 22 days. Although no inhibitory nor stimulatory effect of tamoxifen was seen in vitro, tamoxifen had a clear tumor-growth-stimulating effect in mice. The most pronounced stimulatory effects were observed in the cells that had been cultured with tamoxifen. Within 3 weeks of the start of tamoxifen therapy, the cells grown in the presence of tamoxifen produced tumors with a mean size of 380 mm2, whereas the cells not pretreated with tamoxifen had tumors of 220 mm2. In contrast, in mice not receiving tamoxifen, the sizes of the tumors were 190 and 140 mm2, respectively. These preliminary results suggest that prolonged in vitro tamoxifen exposure induces cellular changes that result in tumors that are stimulated to grow faster in mice following tamoxifen treatment.

摘要

一种雌激素受体阴性、多药耐药的MDA-MB-A1人乳腺癌细胞系在含有和不含有非抑制浓度(0.5微摩尔)他莫昔芬的培养基中培养122天。将经他莫昔芬处理的细胞和对照细胞接种到9只裸鼠的双侧胁腹,在每种情况下它们都产生了可测量的肿瘤。其中6只动物每天接受500微克他莫昔芬治疗22天。虽然在体外未观察到他莫昔芬的抑制或刺激作用,但他莫昔芬在小鼠中具有明显的肿瘤生长刺激作用。在用他莫昔芬培养的细胞中观察到最明显的刺激作用。在他莫昔芬治疗开始后的3周内,在他莫昔芬存在下生长的细胞产生的肿瘤平均大小为380平方毫米,而未用他莫昔芬预处理的细胞产生的肿瘤大小为220平方毫米。相比之下,在未接受他莫昔芬治疗的小鼠中,肿瘤大小分别为190和140平方毫米。这些初步结果表明,体外长期暴露于他莫昔芬会诱导细胞变化,导致肿瘤在接受他莫昔芬治疗后在小鼠中生长加快。

相似文献

1
Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer.他莫昔芬可刺激耐药物雌激素受体阴性乳腺癌在体内的生长。
Cancer Chemother Pharmacol. 1993;32(5):396-8. doi: 10.1007/BF00735926.
2
Prolonged tamoxifen exposure selects a breast cancer cell clone that is stable in vitro and in vivo.长期暴露于他莫昔芬会筛选出一种在体外和体内均稳定的乳腺癌细胞克隆。
Eur J Cancer. 1993;29A(15):2138-44. doi: 10.1016/0959-8049(93)90049-l.
3
Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.生理浓度雌二醇对无胸腺小鼠体内他莫昔芬刺激生长的乳腺肿瘤的抗肿瘤作用。
Clin Cancer Res. 2000 May;6(5):2028-36.
4
Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.用于研究“激素依赖性”乳腺癌和子宫内膜癌的免疫缺陷动物。
J Steroid Biochem. 1989;34(1-6):169-76. doi: 10.1016/0022-4731(89)90079-4.
5
Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.在人乳腺癌模型中,纯甾体类抗雌激素与他莫昔芬的效果比较。
J Natl Cancer Inst. 1995 May 17;87(10):746-50. doi: 10.1093/jnci/87.10.746.
6
Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.雌二醇对注射过表达蛋白激酶Cα的T47D乳腺癌细胞系的无胸腺小鼠的新型抗肿瘤作用。
Clin Cancer Res. 2001 Oct;7(10):3156-65.
7
cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo.进行cDNA转染,随后分离出在体外和体内对他莫昔芬耐药的MCF-7乳腺癌细胞系。
Br J Cancer. 1993 Dec;68(6):1088-96. doi: 10.1038/bjc.1993.486.
8
The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.苏拉明对他莫昔芬敏感和耐药的人乳腺癌细胞系的抗增殖作用与表皮生长因子和胰岛素样生长因子-I受体表达的关系:在他莫昔芬存在下的生长刺激作用
Ann Oncol. 1998 Feb;9(2):205-11. doi: 10.1023/a:1008241804078.
9
The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.一线使用芳香化酶抑制剂来曲唑治疗后,二线抗雌激素治疗对绝经后乳腺癌模型肿瘤内芳香化酶的乳腺肿瘤生长的影响:长期研究
Clin Cancer Res. 2002 Jul;8(7):2378-88.
10
Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.在无胸腺小鼠体内生长的他莫昔芬刺激的乳腺肿瘤中,三苯乙烯类抗雌激素存在交叉耐药性,但 ICI 182,780 不存在交叉耐药性。
Clin Cancer Res. 2000 Dec;6(12):4893-9.

引用本文的文献

1
Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer.乳腺癌辅助激素治疗与对侧乳腺癌激素受体特异性亚型的风险
Cancer Res. 2009 Sep 1;69(17):6865-70. doi: 10.1158/0008-5472.CAN-09-1355. Epub 2009 Aug 25.
2
Reduced tamoxifen accumulation is not associated with stimulated growth in tamoxifen resistance.他莫昔芬蓄积减少与他莫昔芬耐药中的生长刺激无关。
Cancer Chemother Pharmacol. 1994;35(2):149-52. doi: 10.1007/BF00686638.

本文引用的文献

1
Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.他莫昔芬及其他三苯乙醇类似物逆转P388小鼠白血病细胞对阿霉素的获得性耐药
Cancer Res. 1984 Oct;44(10):4392-5.
2
The pharmacology and clinical uses of tamoxifen.他莫昔芬的药理学及临床应用。
Pharmacol Ther. 1984;25(2):127-205. doi: 10.1016/0163-7258(84)90043-3.
3
Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.早期激素环境改变对大鼠致癌物诱导乳腺肿瘤的发育及激素依赖性的影响。
Cancer Res. 1983 Nov;43(11):5342-6.
4
Project of experimental bioassays on chemoprevention agents performed at the Bologna Institute of Oncology: report on tamoxifen control of spontaneous mammary tumors on Sprague-Dawley rats.在博洛尼亚肿瘤研究所进行的化学预防剂实验生物测定项目:他莫昔芬对斯普拉格-道利大鼠自发性乳腺肿瘤控制情况的报告。
Cancer Invest. 1988;6(5):643-58. doi: 10.3109/07357908809082136.
5
Elevated plasma tamoxifen levels in a patient with liver obstruction.
Cancer Chemother Pharmacol. 1989;23(3):194-5. doi: 10.1007/BF00267955.
6
Tamoxifen as risk factor for carcinoma of corpus uteri.他莫昔芬作为子宫体癌的危险因素。
Lancet. 1988 Sep 3;2(8610):563. doi: 10.1016/s0140-6736(88)92675-x.
7
Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro.抗雌激素在体内和体外刺激乳腺癌细胞(MCF-7)生长的差异能力。
Cancer Res. 1989 Sep 1;49(17):4765-9.
8
Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers.早期乳腺癌辅助性他莫昔芬治疗:新发原发性癌症的发生情况
Lancet. 1989 Jan 21;1(8630):117-20. doi: 10.1016/s0140-6736(89)91141-0.
9
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.采用酸性硫氰酸胍-苯酚-氯仿萃取法一步分离RNA的方法。
Anal Biochem. 1987 Apr;162(1):156-9. doi: 10.1006/abio.1987.9999.
10
Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer.早期乳腺癌辅助他莫昔芬治疗和放疗后新发原发性癌症的发病率。
J Natl Cancer Inst. 1991 Jul 17;83(14):1013-7. doi: 10.1093/jnci/83.14.1013.